New Republic Capital, LLC

Position in MRK — Merck & Co., Inc.

CIK 1989988 CHARLOTTE, NC

Position in MRK

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$1,465,157

+$412,740 QoQ

Shares Held

11,402

+30.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.49%

of 13F equity value

Holder Rank

#1,814

of 3,769 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

New Republic Capital, LLC holds $13,477,197 across 11 Drug Manufacturers - General names. MRK ranks #4 (10.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	3,001	$3,599,489
2	JNJ	Johnson & Johnson	8,090	$2,054,617
3	AMGN	Amgen Inc	4,966	$1,798,287
4	MRK	Merck & Co., Inc. This page	11,402	$1,465,157
5	BMY	Bristol Myers Squibb Co	17,698	$1,019,758
6	ABBV	AbbVie Inc.	3,936	$990,455
7	PFE	Pfizer Inc	25,574	$615,821
8	NVS	Novartis AG	3,729	$584,408

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,465,157	11,402	+30.3%	Shares	Sole	2026-07-31
2026-03-31	$1,052,417	8,749	-29.5%	Shares	Sole	2026-05-01
2025-12-31	$1,306,592	12,413	+99.5%	Shares	Sole	2026-02-10
2025-09-30	$522,128	6,221	+7.8%	Shares	Sole	2025-10-27
2025-06-30	$456,674	5,769	+8.1%	Shares	Sole	2025-08-12
2025-03-31	$479,228	5,339	+7.8%	Shares	Sole	2025-05-07
2024-12-31	$492,823	4,954	+8.5%	Shares	Sole	2025-01-29
2024-09-30	$518,401	4,565	+2.0%	Shares	Sole	2024-11-04
2024-06-30	$554,252	4,477	+2.1%	Shares	Sole	2024-08-14
2024-03-31	$578,468	4,384	-7.7%	Shares	Sole	2024-05-07
2023-12-31	$517,735	4,749	+31.5%	Shares	Sole	2024-02-12
2023-09-30	$371,855	3,612	+0.6%	Shares	Sole	2023-11-14
2023-06-30	$414,250	3,590	+9.2%	Shares	Sole	2023-08-14
2023-03-31	$349,810	3,288	+23.9%	Shares	Sole	2023-09-12
2022-12-31	$294,461	2,654	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.